Prelude Capital Management’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-41,480
Closed -$412K 1824
2022
Q3
$412K Hold
41,480
0.01% 730
2022
Q2
$408K Hold
41,480
0.01% 904
2022
Q1
$407K Buy
+41,480
New +$405K 0.01% 944

Prelude Capital Management's HCAR Position: Q4 2022 in Review

Prelude Capital Management sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 41,480 shares — an estimated $412K sold.

Prelude Capital Management first reported a position in HCAR in Q1 2022 and held it in 3 quarters. The position peaked at $412K in Q3 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

  • Prelude Capital Management reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Prelude Capital Management sold 41,480 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $412K.
  • Prelude Capital Management first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Prelude Capital Management's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $412K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.